References
1. Sawada T, Fujimori D, Yamamoto Y. Systemic lupus erythematosus and
immunodeficiency. Immunological medicine. 2019:1-9.
2. Gatto M, Iaccarino L, Ghirardello A, Punzi L, Doria A. Clinical and
pathologic considerations of the qualitative and quantitative aspects of
lupus nephritogenic autoantibodies: A comprehensive review. J Autoimmun.
2016;69:1-11.
3. Oltvai ZN, Milliman CL, Korsmeyer SJ. Bcl-2 heterodimerizes in vivo
with a conserved homolog, Bax, that accelerates programmed cell death.
Cell. 1993;74(4):609-19.
4. Salem MN, Taha HA, Abd El-Fattah El-Feqi M, Eesa NN, Mohamed RA.
Urinary TNF-like weak inducer of apoptosis (TWEAK) as a biomarker of
lupus nephritis. Z Rheumatol. 2018;77(1):71-7.
5. Choe JY, Kim SK. Serum TWEAK as a biomarker for disease activity of
systemic lupus erythematosus. Inflamm Res. 2016;65(6):479-88.
6. Mahajan A, Herrmann M, Munoz LE. Clearance Deficiency and Cell Death
Pathways: A Model for the Pathogenesis of SLE. Front Immunol. 2016;7:35.
7. Nguyen TT, Baumgarth N. Natural IgM and the Development of B
Cell-Mediated Autoimmune Diseases. Crit Rev Immunol. 2016;36(2):163-77.
8. Baumgarth N, Herman OC, Jager GC, Brown L, Herzenberg LA, Herzenberg
LA. Innate and acquired humoral immunities to influenza virus are
mediated by distinct arms of the immune system. Proceedings of the
National Academy of Sciences of the United States of America.
1999;96(5):2250-5.
9. Weller S, Braun MC, Tan BK, Rosenwald A, Cordier C, Conley ME, et al.
Human blood IgM ”memory” B cells are circulating splenic marginal zone B
cells harboring a prediversified immunoglobulin repertoire. Blood.
2004;104(12):3647-54.
10. Zhang X. Regulatory functions of innate-like B cells. Cell Mol
Immunol. 2013;10(2):113-21.
11. Hu F, Zhang W, Shi L, Liu X, Jia Y, Xu L, et al. Impaired
CD27(+)IgD(+) B Cells With Altered Gene Signature in Rheumatoid
Arthritis. Front Immunol. 2018;9:626.
12. Hochberg MC. Updating the American College of Rheumatology revised
criteria for the classification of systemic lupus erythematosus.
Arthritis Rheum. 1997;40(9):1725.
13. Gladman DD, Ibanez D, Urowitz MB. Systemic lupus erythematosus
disease activity index 2000. J Rheumatol. 2002;29(2):288-91.
14. Mistry P, Kaplan MJ. Cell death in the pathogenesis of systemic
lupus erythematosus and lupus nephritis. Clin Immunol. 2017;185:59-73.
15. Biermann MH, Veissi S, Maueroder C, Chaurio R, Berens C, Herrmann M,
et al. The role of dead cell clearance in the etiology and pathogenesis
of systemic lupus erythematosus: dendritic cells as potential targets.
Expert Rev Clin Immunol. 2014;10(9):1151-64.
16. Munoz LE, van Bavel C, Franz S, Berden J, Herrmann M, van der Vlag
J. Apoptosis in the pathogenesis of systemic lupus erythematosus. Lupus.
2008;17(5):371-5.
17. Quartier P, Potter PK, Ehrenstein MR, Walport MJ, Botto M.
Predominant role of IgM-dependent activation of the classical pathway in
the clearance of dying cells by murine bone marrow-derived macrophages
in vitro. Eur J Immunol. 2005;35(1):252-60.
18. Munoz LE, Janko C, Schulze C, Schorn C, Sarter K, Schett G, et al.
Autoimmunity and chronic inflammation - two clearance-related steps in
the etiopathogenesis of SLE. Autoimmun Rev. 2010;10(1):38-42.
19. Gronwall C, Akhter E, Oh C, Burlingame RW, Petri M, Silverman GJ.
IgM autoantibodies to distinct apoptosis-associated antigens correlate
with protection from cardiovascular events and renal disease in patients
with SLE. Clin Immunol. 2012;142(3):390-8.
20. Wei C, Anolik J, Cappione A, Zheng B, Pugh-Bernard A, Brooks J, et
al. A new population of cells lacking expression of CD27 represents a
notable component of the B cell memory compartment in systemic lupus
erythematosus. J Immunol. 2007;178(10):6624-33.
21. Rodriguez-Bayona B, Ramos-Amaya A, Perez-Venegas JJ, Rodriguez C,
Brieva JA. Decreased frequency and activated phenotype of blood CD27 IgD
IgM B lymphocytes is a permanent abnormality in systemic lupus
erythematosus patients. Arthritis Res Ther. 2010;12(3):R108.
22. Chang NH, Li TT, Kim JJ, Landolt-Marticorena C, Fortin PR, Gladman
DD, et al. Interferon-alpha induces altered transitional B cell
signaling and function in Systemic Lupus Erythematosus. J Autoimmun.
2015;58:100-10.
23. Schweighoffer E, Vanes L, Nys J, Cantrell D, McCleary S, Smithers N,
et al. The BAFF receptor transduces survival signals by co-opting the B
cell receptor signaling pathway. Immunity. 2013;38(3):475-88.
24. Sweet RA, Lee SK, Vinuesa CG. Developing connections amongst key
cytokines and dysregulated germinal centers in autoimmunity. Curr Opin
Immunol. 2012;24(6):658-64.
25. Sowell RT, Kaech SM. Probing the Diversity of T Cell Dysfunction in
Cancer. Cell. 2016;166(6):1362-4.
Table 1 SLE patient features